InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.014

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$6 Change of Director's Interest Notice 2 Jul 2020 6:45PM $0.165 $0.014 fallen by 91.52%
$6 Section 708A Notice and Appendix 2A 1 Jul 2020 6:36PM $0.175 $0.014 fallen by 92%
$6 ResAppDx-EU to be Launched on Phenix Health Telehealth App 1 Jul 2020 10:07AM $0.175 $0.014 fallen by 92%
$6 Coviu and ResApp Health Sign Service Agreement 1 Jul 2020 9:30AM $0.175 $0.014 fallen by 92%
$6 Ilara and ResApp Announce Evaluation of ResAppDx in Africa 30 Jun 2020 8:46AM $0.175 $0.014 fallen by 92%
$6 SleepCheck App for iPhone Now Available on the App Store 29 Jun 2020 9:05AM $0.185 $0.014 fallen by 92.43%
$6 DARPA WASH Program Update 29 Jun 2020 8:47AM $0.185 $0.014 fallen by 92.43%
$6 ResApp Signs MOU to Develop Respiratory App for Consumers 18 Jun 2020 8:35AM $0.190 $0.014 fallen by 92.63%
$6 Phenix and ResApp Sign Software Licensing Agreement 16 Jun 2020 8:51AM $0.175 $0.014 fallen by 92%
$6 S&P DJI Announces June 2020 Quarterly Rebalance 12 Jun 2020 8:16AM $0.175 $0.014 fallen by 92%
$6 German Health-Economic Evaluation and Update on COPD Study 2 Jun 2020 9:31AM $0.180 $0.014 fallen by 92.22%
$6 ResApp to Present at TechKnow Invest Roadshow Webinar 11 May 2020 4:19PM $0.185 $0.014 fallen by 92.43%
$6 ResAppDx-EU in Use at COVID-19 Respiratory Clinic 11 May 2020 9:22AM $0.160 $0.014 fallen by 91.25%
$6 Change in substantial holding 11 May 2020 8:15AM $0.160 $0.014 fallen by 91.25%
$6 Section 708A Notice and Appendix 2A 6 May 2020 3:54PM $0.165 $0.014 fallen by 91.52%
$6 ResApp Receives Final Design Files for Hardware Devices 6 May 2020 10:13AM $0.175 $0.014 fallen by 92%
$6 Quarterly Update and Appendix 4C 30 Apr 2020 9:14AM $0.175 $0.014 fallen by 92%
$6 Investor Presentation 22 Apr 2020 9:47AM $0.155 $0.014 fallen by 90.97%
$6 Appendix 3G 7 Apr 2020 6:33PM $0.185 $0.014 fallen by 92.43%
$6 Initial Director's Interest Notice 6 Apr 2020 7:04PM $0.195 $0.014 fallen by 92.82%
$6 ResApp Appoints Dr Michael Stein as a Non-Executive Director 6 Apr 2020 9:02AM $0.185 $0.014 fallen by 92.43%
$6 ResApp Announces SleepCheck, a Sleep Apnoea Screening App 1 Apr 2020 9:32AM $0.195 $0.014 fallen by 92.82%
$6 Final Director's Interest Notice 31 Mar 2020 7:51PM $0.195 $0.014 fallen by 92.82%
$6 Coviu and ResApp Complete Initial ResAppDx-EU Integration 30 Mar 2020 10:01AM $0.140 $0.014 fallen by 90%
$6 Resignation of Non-Executive Director 30 Mar 2020 9:37AM $0.140 $0.014 fallen by 90%

251 - 275 of 589 results

Page 11 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.